Hims & Hers (HIMS) Investors Keep the Faith as Stock Slides 15%

Tip Ranks
2025.11.18 23:51
portai
I'm PortAI, I can summarize articles.

Hims & Hers Health (HIMS) stock has dropped over 15% since last week, following its Q3 update. Concerns include GLP-1 dependence, margin pressure, and increased spending, which may challenge the telehealth business's sustainability. Despite the decline, investors remain hopeful.

If you only glance at the share price, you might think the Hims & Hers Health (HIMS) story has lost its spark. The stock has declined by more than 15% since last week. In fact, post its Q3 update, the stock has recorded heavy declines, with bears highlighting GLP-1 dependence, margin pressure, and a fresh wave of spending as being insufficient to sustain the telehealth story moving forward.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.